Cargando…

NLRP3 Inflammasome and Pathobiology in AMD

Age-related macular degeneration (AMD) is the leading cause of central vision loss and blindness in the elderly. It is characterized by a progressive loss of photoreceptors in the macula due to damage to the retinal pigment epithelium (RPE). Clinically, it is manifested by drusen deposition between...

Descripción completa

Detalles Bibliográficos
Autores principales: Celkova, Lucia, Doyle, Sarah L., Campbell, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470247/
https://www.ncbi.nlm.nih.gov/pubmed/26237026
http://dx.doi.org/10.3390/jcm4010172
_version_ 1782376738211233792
author Celkova, Lucia
Doyle, Sarah L.
Campbell, Matthew
author_facet Celkova, Lucia
Doyle, Sarah L.
Campbell, Matthew
author_sort Celkova, Lucia
collection PubMed
description Age-related macular degeneration (AMD) is the leading cause of central vision loss and blindness in the elderly. It is characterized by a progressive loss of photoreceptors in the macula due to damage to the retinal pigment epithelium (RPE). Clinically, it is manifested by drusen deposition between the RPE and underlying choroid and accumulation of lipofuscin in the RPE. End-stage disease is characterized by geographic atrophy (dry AMD) or choroidal neovascularization (wet AMD). The NLRP3 inflammasome has recently been implicated in the disease pathology. Here we review the current knowledge on the involvement of this multiprotein complex and its effector cytokines interleukin-1β (IL-1β) and IL-18 in AMD progression. We also describe cell death mechanisms that have been proposed to underlie RPE degeneration in AMD and discuss the role of autophagy in the regulation of disease progression.
format Online
Article
Text
id pubmed-4470247
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44702472015-07-28 NLRP3 Inflammasome and Pathobiology in AMD Celkova, Lucia Doyle, Sarah L. Campbell, Matthew J Clin Med Review Age-related macular degeneration (AMD) is the leading cause of central vision loss and blindness in the elderly. It is characterized by a progressive loss of photoreceptors in the macula due to damage to the retinal pigment epithelium (RPE). Clinically, it is manifested by drusen deposition between the RPE and underlying choroid and accumulation of lipofuscin in the RPE. End-stage disease is characterized by geographic atrophy (dry AMD) or choroidal neovascularization (wet AMD). The NLRP3 inflammasome has recently been implicated in the disease pathology. Here we review the current knowledge on the involvement of this multiprotein complex and its effector cytokines interleukin-1β (IL-1β) and IL-18 in AMD progression. We also describe cell death mechanisms that have been proposed to underlie RPE degeneration in AMD and discuss the role of autophagy in the regulation of disease progression. MDPI 2015-01-14 /pmc/articles/PMC4470247/ /pubmed/26237026 http://dx.doi.org/10.3390/jcm4010172 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Celkova, Lucia
Doyle, Sarah L.
Campbell, Matthew
NLRP3 Inflammasome and Pathobiology in AMD
title NLRP3 Inflammasome and Pathobiology in AMD
title_full NLRP3 Inflammasome and Pathobiology in AMD
title_fullStr NLRP3 Inflammasome and Pathobiology in AMD
title_full_unstemmed NLRP3 Inflammasome and Pathobiology in AMD
title_short NLRP3 Inflammasome and Pathobiology in AMD
title_sort nlrp3 inflammasome and pathobiology in amd
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470247/
https://www.ncbi.nlm.nih.gov/pubmed/26237026
http://dx.doi.org/10.3390/jcm4010172
work_keys_str_mv AT celkovalucia nlrp3inflammasomeandpathobiologyinamd
AT doylesarahl nlrp3inflammasomeandpathobiologyinamd
AT campbellmatthew nlrp3inflammasomeandpathobiologyinamd